Arginine dimethylation products in pediatric patients with chronic kidney disease

Abstract Background arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD). We aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney fun...

Full description

Saved in:
Bibliographic Details
Published in:Annals of medicine and surgery 2016-08, Vol.9, p.22-27
Main Authors: El-Sadek, Akram E, Behery, Eman G, Azab, Ahmed A, Kamal, Naglaa M, Salama, Mostafa A, Abdulghany, Waleed E, Abdallah, Enas A.A
Format: Article
Language:English
Subjects:
Chronic kidney disease
Internal Medicine
Kidney functions
Original Research
Serum arginine
Serum dimethyl arginine derivatives
Surgery
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Abstract Background arginine and its metabolites have been linked to pediatric chronic kidney disease (CKD). We aimed to estimate serum levels of argninine (Arg), asymmetric dimethylarginine (ADMA) and symmetric dimethylarginine (SDMA) in pediatric CKD patients and its relation to altered kidney function. Patients and methods 132 pediatric patients with CKD and 120 healthy age and sex matched controls were compared regarding; serum Arg, ADMA and SDMA levels. Results In comparison to their values in control subjects, serum Arg levels were significantly lower; serum ADMA levels were non-significantly higher, but serum SDMA levels were significantly higher in CKD patients (p values: < 0.000; = 0.054;
ISSN:2049-0801
2049-0801
DOI:10.1016/j.amsu.2016.05.017